Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

In Europe, these therapies were introduced between 2006 and 2013. The anti-TNF era was followed by the emergence of interleukin (IL) inhibitors, with J&J’s Stelara (ustekinumab) leading the way ...

Shares of PDS Biotechnology Corporation (PDSB) drew investor attention on Thursday after the company reported ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

The Controller Bar and XBOX Game Pass widget make it easier to play. Windows 11 is the most secure version of Windows yet. It's important for security to be invisible so you can focus on using your PC ...

EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...

Elevated IL-26 levels in the nose of smokers with and without COPD may provide a simple method for early detection and ...

Colorectal cancer is no longer a disease of older people. People in their 50s, 40s and younger are increasingly being ...

In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo ...

Macrophages control intracellular pathogens like Salmonella by using two caspase enzymes at different times during infection.